Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Takeda Pharmaceutical Company Limited
  6. Company
    4502   JP3463000004

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Number of employees : 47 099 people.
Sales per Business
20202021Delta
Gastroenterology697 896.0021.2%777 800.0024.3% +11.45%
Other704 763.0021.4%574 068.0018% -18.54%
Plasma-derived Therapies Immunology394 165.0012%420 389.0013.1% +6.65%
Neuroscience438 520.0013.3%417 297.0013% -4.84%
Oncology420 956.0012.8%416 512.0013% -1.06%
Rare Hematology334 240.0010.2%289 799.009.1% -13.3%
Rare Metabolic170 825.005.2%162 620.005.1% -4.8%
Hereditary Angioedema129 823.003.9%139 327.004.4% +7.32%
JPY in Million
Sales per region
20202021Delta
United States1 595 920.0048.5%1 567 930.0049% -1.75%
Europe and Canada645 528.0019.6%666 177.0020.8% +3.2%
Japan592 786.0018%559 748.0017.5% -5.57%
Asia165 401.005%156 240.004.9% -5.54%
Latin America143 456.004.4%121 638.003.8% -15.21%
Other71 260.002.2%68 518.002.1% -3.85%
Russia / Commonwealth of Independent States76 835.002.3%57 560.001.8% -25.09%
JPY in Million
Managers
Name Title Age Since
Christophe Weber President, CEO & Representative Director 54 2015
Constantine Saroukos Chief Financial Officer & Director 50 2019
Andrew Plump Director, Research & Development President 55 2019
Michael Mendelsohn Chief Medical & Scientific Officer 65 2015
Norimasa Takeda Chief Accounting Officer & Corporate Controller - -
Masahiro Sakane Independent Outside Director 80 2014
Shiro Kuniya Independent Outside Director 64 2016
Yoshiaki Fujimori Independent Director 69 2016
Emiko Higashi Independent Outside Director 61 2016
Michel Orsinger Independent Outside Director 63 2016
Members of the board
Name Title Age Since
Yasuhiko Yamanaka Director 65 2016
Masato Iwasaki, Dr. Director & President-Japan Pharma Business Unit 62 2015
Christophe Weber President, CEO & Representative Director 54 2015
Andrew Plump Director, Research & Development President 55 2019
Masahiro Sakane Independent Outside Director 80 2014
Shiro Kuniya Independent Outside Director 64 2016
Yoshiaki Fujimori Independent Director 69 2016
Emiko Higashi Independent Outside Director 61 2016
Michel Orsinger Independent Outside Director 63 2016
Toshiyuki Shiga Independent Outside Director 67 2016
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0.01 1,578,945,793 1,567,680,236 99.3% 9,723,017 0.6% 99.3%
Shareholders
NameEquities%
Nomura Asset Management Co., Ltd. 65,203,490 4.12%
BlackRock Fund Advisors 51,074,730 3.23%
The Vanguard Group, Inc. 37,925,477 2.40%
Nippon Life Insurance Co. 35,360,000 2.23%
Daiwa Asset Management Co. Ltd. 32,140,391 2.03%
Nikko Asset Management Co., Ltd. 30,317,196 1.92%
BlackRock Japan Co., Ltd. 23,218,800 1.47%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. 14,866,692 0.94%
Baillie Gifford & Co. 11,809,000 0.75%
Takeda Pharmaceutical Employee Incentive Plan 11,300,881 0.71%
Holdings
NameEquities%Valuation
DENALI THERAPEUTICS INC. (DNLI) 4,214,559 3.46% 224,214,539 USD
DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) 6,470,382 10.4% 180,070,731 USD
MIRUM PHARMACEUTICALS, INC. (MIRM) 1,859,151 6.09% 30,211,204 USD
OVID THERAPEUTICS INC. (OVID) 7,531,996 11.1% 26,587,946 USD
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. (4886) 2,204,840 7.21% 20,410,733 USD
MOLECULAR TEMPLATES, INC. (MTEM) 2,314,659 4.12% 15,091,577 USD
BIOMX INC. (PHGE) 2,470,935 8.76% 9,809,612 USD
HOOKIPA PHARMA INC. (HOOK) 1,333,588 5.11% 9,188,421 USD
WAVE LIFE SCIENCES LTD. (WVE) 1,096,892 2.16% 6,943,326 USD
OHKI HEALTHCARE HOLDINGS CO.,LTD. (3417) 500,000 3.55% 4,369,195 USD
Markets and indexes
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  4502:JP
- Reuters Code :  4502.T
- Datastream Code :  
Company contact information
Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome
JP-540-8645 Nishi-ku, Osaka

Phone : +81 6 6204 2111
Fax : +81 6 6204 2880
web site : http://www.takeda.co.jp
Brand Portfolio
In partnership withAllbrands.markets
More brands of Takeda Pharmaceutical Company Limited
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.40%53 671
JOHNSON & JOHNSON4.16%431 543
ROCHE HOLDING AG10.05%322 644
PFIZER, INC.19.32%246 414
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY35.22%206 972
ABBVIE INC.-0.69%188 045
NOVARTIS AG-8.39%185 853
MERCK & CO., INC.-11.93%182 360
ASTRAZENECA PLC17.65%182 344
BRISTOL-MYERS SQUIBB COMPANY-3.03%133 660
SANOFI5.12%121 897
AMGEN INC.-7.08%121 316
GLAXOSMITHKLINE PLC6.48%97 696
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-24.86%62 044
DAIICHI SANKYO COMPANY, LIMITED-12.76%53 936
BAYER AG-3.31%53 694
JIANGSU HENGRUI MEDICINE CO., LTD.-48.55%47 234
ASTELLAS PHARMA INC.16.91%31 513
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY50.32%24 839